ASO Author Reflections: Rationale to Routinely Retest ER, PR and HER-2/neu Receptor Status in Residual Disease After Neoadjvuant Chemotherapy

  • 0Department of Surgery, University of California San Francisco, San Francisco, CA, USA.

|

|

Summary

No abstract available on PubMed